Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Digital Health Today-Resources Digital Health Today Ambassadors

Digital Health Today Podcasts

Accelerating innovation and implementation of health technology
Subscribe
Advertisement

Latest Episodes

Showing 1 - 8 of 224

Digital Therapeutics Alliance (DTA): The Next Chapter in Scaling the DTx Industry

In this episode, we hear from Andy Molnar, CEO at the Digital Therapeutics Alliance. Andy dives into what they are working on to propel the DTx industry forward, and the international scope of his work in Europe, Asia Pacific and beyond. We also discuss the recent trends with commercial payers and reimbursements - or lack thereof - and much more. Key Takeaway: Be sure to check out the link to the DTx Value Assessment and Integration Guide put together by the DTx Alliance. It is designed to support healthcare decision makers as they assess and integrate DTx products into clinical use settings.  Guest Links and Resources: Learn more about Digital Therapeutics Alliance | Twitter | LinkedIn Connect with Andy Molnar Download the DTx Value Assessment & Integration Guide Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

DTx Rewind and Where We Go From Here

We’ve got a very special guest on this episode. In Season 2 of DTx Podcast, we will focus greater attention on the evidence and commercialization of Digital Therapeutics. To bring even more context and insights to these conversations, I'm excited to introduce my partner this season: Dr. Chandana Fitzgerald, or as you’ll hear her own name of choice - "Dr No Craic"! Don't worry, the name will be explained in this episode. Join us as we briefly rewind the past year in DTx as we discuss SPAC’s and going public, new entrants and exits in the DTx space, and much more. Chandana also asks me a few questions about the history and goal of the DTx Podcast and what we have to look forward to in season two. But before we dive in… I remember when Martin Kelly introduced me to Chandana at one of the HealthXL events about 5 years ago. Chandana was witty, sharp and fun to speak with. Chandana comes from a clinical background as a physician, and is now the Chief Medical Officer and General Manager of HealthXL. And, as you'll here in this first episode of Season 2 of DTx Podcast, she's also my clinical and commercialization partner with all the tough questions for our guests!  Links and Resources: Brian Dolan Martin Kelly Ed Cox Dan Kendall Better Therapeutics Pear Therapeutics Akili Interactive Pierre Leurent Cognito Therapeutics Digital Therapeutics Alliance Mark Sluijs Alex Therapeutics Karuna Labs Nightware Smiley Scope Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Introducing Season 2 of Digital Therapeutics Podcast!!

In this episode, we officially announce that the Digital Therapeutics Podcast is back for Season 2!  And the good news keeps coming as Eugene Borukhovich resumes his role as the talented host of the series! Eugene is a serial intra- and entrepreneur, executive, venture builder, speaker & board advisor with a focus in digital health. He’s also the COO and co-founder at YourCoach.Health, the leading health coaching ecosystem working to deliver the power of health coaching to the world’s population.  Eugene is using his voice to make some noise about the exciting things happening in healthcare and specifically in Digital Therapeutics. Tune in as we share the success to date, what caused him to resume his hosting duties, and what's in store for Season 2! Links: Season 1, Episode 13 with Chris Bergstrom April Fool's Post: A DTx to Overcome Podcast Hesitancy Host Links and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

What is Enterprise Blockchain? How is it Used?

This episode is all about what enterprise blockchain is and how it can be used! We are honored to feature Radhika Inyegar, co-author of the book “Enterprise Blockchain Has Arrived”. She shares with us how the blockchain came about conceptually, the differences between proof of work versus proof of stake, the different roles for permission and permission-less systems, smart contracts and the impact it will have on healthcare. Blockchain is essentially a database that has multiple owners, so everyone sees and has access to the same information. Right now, blockchain is used in the non-PHI side of healthcare.  Blockchain is all about truth and transparency in the transactions involved, and their application to healthcare is going to change the game.  About Rhadika Inyegar Radhika Iyengar is a TEDx and keynote speaker, author, Silicon Valley Woman of Influence, and a serial entrepreneur. She is Founding Partner at StarChain Ventures, a Silicon Valley-based venture studio focused on the convergence of advanced technologies including Blockchain, AI and IoT. She is also Managing Partner of DoubleNova Group, a global advanced tech advisory company based in Silicon Valley. Radhika is a co-author of the critically acclaimed book Enterprise Blockchain Has Arrived. As an enterprise blockchain expert, she has advised companies globally in the healthcare, fintech and supply chain sectors. She is a member of the Government Blockchain Association as well as the California Gov Ops Blockchain Working Group, a task force advising California state legislature, where she has advised on a wide range of areas such as healthcare, life sciences and pharma supply chains, digital identity, privacy, sustainability, and food and agriculture supply chains. Radhika is an Advisory Board Member and Global Ambassador of Blockchain in Healthcare Today (BHTY), the world’s first peer-reviewed journal on blockchain in healthcare. Key Take-aways  The Internet changed the world, and blockchain is on its way to do the same.  Blockchain is a distributed ledger technology which allows multiple owners to have ownership of the data that's within it. Once a change is made in a blockchain, it is immutable.  In blockchain all of the blocks of information are tied to each other.  Blockchain does not store data, it stores the hash of the record.  Guest Links and Resources: Connect and Follow Radhika on LinkedIn: https://www.linkedin.com/in/radhikaiyengar13/  Follow Radhika on Twitter: https://twitter.com/RIyengar13  Grab your copy of the book “Enterprise Blockchain Has Arrived” by Radhika Inyegar and Jorden Woods here: https://www.amazon.com/Enterprise-Blockchain-Has-Arrived-Deployments-ebook/dp/B07Z3LJCHW 
March 30, 2022 by Digital Health 101

S2.E8: Changing the Way Insurers Interact with Their Customers – a Conversation with Paul Hughes from UnderwriteMe

Globally, the insurance industry is rapidly changing with the increasing use of technology throughout the value chain. And because individuals in Asia Pacific tend to buy and use health insurance from life insurers, the need for data, customer engagement, and digital transformation is particularly essential. In this episode, I speak with Paul Hughes, the Head of Asia Pacific for UnderwriteMe. Paul and I first worked together at MetLife Asia many years ago, and he has worked across Asia Pacific for many other private insurers. In his current role, he is at the epicenter of the change spurred by technology and data, including digital health. In this episode, we discuss: • The structure of the typical insurance, from sales to operations • How technology and data are changing the way insurers need to operate • The role of digital tools including health and insurtech • The future of underwriting Paul Hughes Paul leads the Asia Pacific team at UnderwriteMe, a leading provider of underwriting automation solutions that helps insurers transform their new business process. He is responsible for creating and leading the growth strategy for the business in Asia Pacific and ensuring client success. With over 25 years of experience in the life and health insurance industry in Asia Pacific, he had held senior roles in Underwriting, Claims, Operations, Product and Marketing with leading insurers and reinsurers such as Swiss Re, Aviva, AIA, and MetLife. Guest's Links and Resources Connect with Paul Hughes: LinkedIn UnderwriteMe: Website | LinkedIn | Twitter | Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
December 9, 2021 by Asia Pacific Edition

S2.E7: Moving beyond the traditional role of academia in healthcare – a profile of Dean Ho from National University of Singapore

The role of academia is an essential one for digital health. In addition to providing the platform to conduct clinical research and showcase where technology can create impact, the right environment also becomes the training ground for future leaders and change makers. In this episode, I speak with Dean Ho, who is one of the unique individuals who effectively bridges the different worlds of academia and business building. Dean is the Provost’s Chair Professor, Director of The N.1 Institute for Health (N.1), Director of the Institute for Digital Medicine (WisDM), and Head of the Department of Biomedical Engineering at the National University of Singapore. He's also an experienced business builder and entrepreneur. In our conversation we cover: • The evolving role of academia in becoming a hands-on partner for Health Innovation • The impact of Digital Health including AI on regulatory • How National University of Singapore is taking a role in designing the next generation of clinical innovation • The need for Digital Therapeutics in APAC Professor Dean Ho Using his CURATE.AI platform, Prof.Dean Ho has led multiple pioneering clinical studies that have validated the promise of N-of-1 medicine, where only a patient’s own data is used to personalise their treatment for the entire duration of care. Multiple CURATE.AI-based clinical studies are ongoing or cleared for start in the areas of solid cancer and blood cancer therapy, digital therapeutics/personalised learning, and post-organ transplant immunosuppression, among others.  Prof. Ho is an elected member of the US National Academy of Inventors (NAI). He is also a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), the Royal Society of Chemistry, and Society for Laboratory Automation and Screening, as well as a Fulbright Scholar. Prof Ho is also currently a Subgroup Lead of the World Health Organization-ITU AI for Health Working Group for Regulatory Considerations. He has also served as the President of the Board of Directors of the Society for Laboratory Automation and Screening (SLAS), a 26,000+ member global drug development organization comprised of senior executives from the pharmaceutical and medical device sectors, as well as academic thought leaders.  Prof. Ho is a recipient of the Tech Heroes from Crisis: Pathfinder Award from the Singapore Computer Society, NSF CAREER Award, Wallace H. Coulter Foundation Translational Research Award, and V Foundation for Cancer Research Scholar Award, among others. Prof. Ho was also named to the Asia Tatler Gen.T List, which honours young leaders who are shaping the future of the region. Prof. Ho has appeared on the National Geographic Channel Program “Known Universe” to discuss his discoveries in drug delivery and imaging. His discoveries have been featured on CNN, The Economist, Forbes, Washington Post, NPR and other international news outlets. He has advised major publicly listed companies as well as venture capital and private equity funds in the areas of digital medicine and pharmaceutical development, among other sectors. Guest's Links and Resources Connect with Dean Ho: LinkedIn | Twitter The N.1 Institute for Health (N.1): Website | Twitter | LinkedIn WisDM: Twitter Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
December 1, 2021 by Asia Pacific Edition

S2.E6: How to Make Concurrent Customer Development Work Effectively in Indonesia with Robyn Soetikno

For some Digital Health companies, especially those in very developed healthcare systems, success can be contingent on identifying a single core problem and then keeping a tight focus on this challenge when iteratively building your great solution. But not every entrepreneur or corporate innovator has the luxury to take this path, especially when there are overlapping areas of need for your customers. In this episode, we return to Indonesia to examine both the challenge and the successful approach taken by Tiffany Robyn Soetikno, the Founder and COO of PT Global Urban Esensial. Robyn is a skilled entrepreneur who grew up in the Indonesian Healthcare industry. The results (so far) from her efforts have led to a startup delivering impact for 2.5 million individuals, 70,000 doctors, and 1,700 pharmacists. In our discussion, we cover: • A summary of the Indonesia healthcare landscape • Building a complex product roadmap and making it work • Her process for deriving consumer insights • Building scale across each of the different customers while managing growth Robyn Soetikno Robyn founded PT Global Urban Esensial (PT GUE, LLC), a leading digital health startup in Indonesia with a vision to reduce the relationship gaps between doctors and patients. Driven to create a health ecosystem that connects different stakeholders, GUE, LLC has developed three pillars: patient management, doctor management and medication supply. Robyn is passionate about enabling stakeholders within the healthcare industry, using technology to address gaps in the healthcare sector. As a startup founder, she has experience in making the jump from zero to one, scaling up, and transforming the team accordingly. She has also assisted several incumbents to grab opportunities in digital. In 2019, Robyn was named 30 Under 30 - Asia - 2019 under Healthcare and Science category. She was the only Indonesian entrepreneur honored by Forbes. Robyn earned her Masters of Science degree in International Health Management from Imperial College, London and her Bachelor of Arts in Psychology, Public Health and Theatre from Sarah Lawrence College, New York. Guest's Links and Resources Connect with Robyn Soetikno: LinkedIn PT Global Urban Esensial: LinkedIn Guesehat: Website | Facebook | Twitter | Instagram | YouTube Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
October 20, 2021 by Asia Pacific Edition

S2.E5: Assessing the Readiness of Japan for Digital Health with Shigeto Miyamoto from BMS Japan

Across Asia Pacific, one persistent challenge is the digital readiness of a health system. Some are more ready for Health Tech than others. The ones that are most prepared have significant adoption of technology, data standards, and processes that embed tech-based solutions into healthcare. In this episode, I’m joined by Shigeto Miyamoto, Head of Digital Marketing for BMS in Japan, and a life-long evangelist for driving technology innovation. In our conversation, we take a deep dive into the current digital readiness in Japan. And while the discussion is specific to one country, the insights from our discussion can be applicable to other health systems. Topics we discuss include: • Cultural reasons why paper-based processes are still prevalent • Gap between the desire to innovate and barriers including regulatory • The impact of COVID on the use of smartphones, telemedicine, and EMRs • Cultural views on privacy and data • The hopeful future for Digital Health in Japan including AI and IoT / Smart Devices Shigeto Miyamoto Based in Tokyo, Shigeto Miyamoto is an experienced digital marketer and thought leader for how technology is driving disruptive innovation in Japan.  Shigeto is currently the Head of Digital Marketing at BMS Japan, where he is the lead for engagement strategy, contents capabilities, and marketing technology.  He has previously worked in insurance at MetLife Japan and held other technology-centric roles at both global enterprises and startups. His career choices are driven by a mission to solve the medical and digital disparities for patients. Shigeto is best known for inspiring marketers to tackle challenging problems through agile thinking and iterative product creation. Guest's Links and Resources Connect with Shigeto Miyamoto: LinkedIn Bristol-Myers Squibb (BMS): Website | LinkedIn | Twitter | Facebook | Instagram Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Bayer G4A Takeda Roche
October 13, 2021 by Asia Pacific Edition
Next Showing 1 - 8 of 224
cover
Digital Therapeutics Alliance (DTA) The Next Chapter in Scaling the DTx Industry
X
X